Melina Miaja

Melina Miaja

Auto-generated profile, based on publicly available information

Melina Miaja

Joven & Fuerte: Programa para la Atencion e Investigacion de Mujeres Jovenes con Cancer de Mama, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2020 in JCO Global Oncology
Verified
Journal Article
Open access
CVCynthia Villarreal-Garza
Cynthia Villarreal-Garza
APAlejandra Platas
Alejandra Platas
MMMelina Miaja
Melina Miaja
AFAlan Fonseca
Alan Fonseca
FMFernanda Mesa-Chavez
Fernanda Mesa-Chavez
MCMauricio Canavati
Mauricio Canavati
PURPOSE: The pilot-phase report of the Joven & Fuerte prospective cohort broadly characterizes and assesses the needs of Mexican young women with breast cancer (YWBC). PATIENTS AND METHODS: Women age ≤ 40 years with nonmetastatic primary breast cancer were consecutively accrued from 2 hospitals. Data were collected at the first/baseline oncology visit and 2 years later using a sociodemographic survey, European Organisation for Research and Treatment of Cancer Quality-of-Life (QOL) Questionnaire Core 30 (QLQ-C30) and Breast Cancer–Specific QOL Questionnaire (QLQ-BR23), Hospital Anxiety and Depression Scale (HADS), Female Sexual Functioning Index (FSFI), Sexual Satisfaction Inventory, and patients’ medical records. Pearson χ2 and 2-sided t tests were used for statistical analysis. An unadjusted P value < .05 was considered significant. RESULTS: Ninety patients were included, all with government health care coverage. Most had low monthly household incomes (98%) and at least a high school education (59%). There was a considerable prevalence of unpartnered patients (36%) and unmet parity (25%). Patients’ most common initial symptom was a palpable mass (84%), and they were most frequently diagnosed with stage III disease (48%), with 51% having had a physician visit ≤ 3 months since detection but 39% receiving diagnosis > 12 months later. At baseline, 66% of patients were overweight/obese, and this proportion had significantly increased by 2 years ( P < .001). Compared with baseline, global QLQ-C30 had improved significantly by 2 years ( P = .004), as had HADS-Anxiety ( P < .001). However, both at baseline and at 2 years, nearly half of patients exhibited FSFI sexual dysfunction. CONCLUSION: These preliminary findings demonstrate that YWBC in Mexico have particular sociodemographic and clinicopathologic characteristics, reinforcing the necessity to further describe and explore the needs of these young patients, because they may better represent the understudied and economically vulnerable population of YWBC in limited-resource settings.

6 April 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ADAlejandro Dominguez-Rodriguez
Alejandro Dominguez-Rodriguez
SSSergio Sanz-Gomez
Sergio Sanz-Gomez
LGLeivy Patricia González-Ramírez
Leivy Patricia González-Ramírez
Paulina Erika Herdoiza-ArroyoPaulina Erika Herdoiza-Arroyo
Paulina Erika Herdoiza-Arroyo
LGLorena Edith Trevino Garcia
Lorena Edith Trevino Garcia
MMMelina Miaja
Melina Miaja
Background: The death of a loved one was a challenge many people faced during the COVID-19 pandemic within the context of extraordinary circumstances and great uncertainty. Grief is an unavoidable part of life, and for most people, feelings of grief decrease naturally over time. However, for some people, grieving can become a particularly painful process with clinical symptoms that may require professional help to resolve. To provide psychological support to people who had lost a loved one during the COVID-19 pandemic, an unguided web-based psychological intervention was developed. Objective: The main objective of this study was to evaluate the efficacy of the web-based treatment, Grief COVID (Duelo COVID in Spanish; ITLAB), in reducing clinical symptoms of complicated grief, depression, posttraumatic stress, hopelessness, anxiety, and suicidal risk in adults. The secondary aim was to validate the usability of the self-applied intervention system. Methods: We used a randomized controlled trial with an intervention group (IG) and a waitlist control group (CG). The groups were assessed 3 times (before beginning the intervention, upon completing the intervention, and 3 months after the intervention). The intervention was delivered on the web in an asynchronous format through the Duelo COVID web page. Participants created an account that could be used on their computers, smartphones, or tablets. The evaluation process was automated as part of the intervention. Results: A total of 114 participants were randomly assigned to the IG or CG and met criteria for inclusion in the study (n=45, 39.5% completed the intervention and n=69, 60.5% completed the waitlist period). Most participants (103/114, 90.4%) were women. The results indicated that the treatment significantly reduced baseline clinical symptoms in the IG for all variables (P<.001 to P=.006), with larger effect sizes for depression, hopelessness, grief, anxiety, and risk of suicide (all effect sizes ≥0.5). The follow-up evaluation showed that symptom reduction was maintained at 3 months after the intervention. The results from the CG showed that participants experienced significantly decreased levels of hopelessness after completing the time on the waitlist (P<.001), but their suicidal risk scores increased. Regarding the usability of the self-applied intervention system, the results indicated a high level of satisfaction with the Grief COVID. Conclusions: The self-applied web-based intervention Grief COVID was effective in reducing symptoms of anxiety, depression, hopelessness, risk of suicide risk, posttraumatic stress disorder, and complicated grief disorder. Grief COVID was evaluated by the participants, who reported that the system was easy to use. These results affirm the importance of developing additional web-based psychological tools to help reduce clinical symptoms in people experiencing grief because of the loss of a loved one during a pandemic. Trial Registration: ClinicalTrials.gov NCT04638842; https://clinicaltrials.gov/ct2/show/NCT04638842

16 April 2019 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
CVCynthia Villarreal-Garza
Cynthia Villarreal-Garza
ELEdna A. López‐Martínez
Edna A. López‐Martínez
BMBertha Alejandra Martinez-Cannon
Bertha Alejandra Martinez-Cannon
APAlejandra Platas
Alejandra Platas
ACAndrea Castro‐Sánchez
Andrea Castro‐Sánchez
CGCarmen Lizette Gálvez‐Hernández
Carmen Lizette Gálvez‐Hernández

1 November 2024 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
PDF file
AGAna Ferrigno Guajardo
Ana Ferrigno Guajardo
BVBryan F Vaca-Cartagena
Bryan F Vaca-Cartagena
FMFernanda Mesa-Chavez
Fernanda Mesa-Chavez
APAlejandra Platas
Alejandra Platas
AFAlan Fonseca
Alan Fonseca
CVCynthia Villarreal-Garza
Cynthia Villarreal-Garza
Young women with breast cancer (YWBC) face unique challenges that can impact their sexual health. This study aimed to identify factors associated with sexual activity, function, and satisfaction in YWBC up to five years post-diagnosis. We conducted a prospective cohort study of 474 women aged ≤40 years diagnosed with non-metastatic breast cancer in Mexico. Sexual function and satisfaction were assessed using the Female Sexual Function Index and the Sexual Satisfaction Inventory, respectively. Factors associated with sexual health outcomes were examined using mixed-effects models. The prevalence of sexual dysfunction increased from 33.6% at baseline to 52.9% at 4-5 years post-diagnosis. Factors associated with worse sexual function included older age (mean predicted FSFI score -1.35, p = .037), treatment-induced amenorrhea (-2.86, p < .001), depression (-4.11, p < .001), and anxiety (-2.13, p < .001). Lower sexual satisfaction was associated with lower educational attainment (mean predicted SSI score -5.61, p = .002), being single (-6.41, p < .001), treatment induced amenorrhea (-3.76, p = .004), bilateral oophorectomy (-8.21, p = .017), depression (-11.29, p < .001), and anxiety (-7.50, p < .001). Quality of life, body image, and systemic therapy side effects significantly impacted both outcomes. Three distinct trajectories of sexual function were identified: high (62.2%), intermediate (24.3%), and markedly declining (13.5%). Four trajectories of sexual satisfaction were found, ranging from intermediate-to-high (57.3%) to progressively worsening (27.5%). Sexual dysfunction is prevalent and persistent among YWBC. Multiple biological, psychological, and social factors influence sexual health outcomes in this population. These findings highlight the importance of routine screening and tailored interventions to address the sexual health of YWBC throughout survivorship.

6 June 2013 in Psicooncología
Verified
Journal Article
Open access
PDF file
MÁMelina Miaja Ávila
Melina Miaja Ávila
JMJosé Moral-de-la-Rubia
José Moral-de-la-Rubia
Los objetivos del estudio fueron: 1) identificar el significado psicológico de las cinco fases del proceso del duelo propuestas por Kübler-Ross, y 2) diseñar una escala para medir las cinco fases del duelo ante la pérdida de la salud desde los resultados obtenidos. Se aplicó un test de asociación libre de palabras con la técnica de redes semánticas naturales a una muestra no probabilística intencional de 18 pacientes oncológicos y 12 cuidadores primarios. Se encontraron que las asociaciones de palabras eran congruentes con la expectativa teórica. A partir de estas palabras y algunas consideraciones teóricas se redactaron 67 ítems. Al ser sometidos al juicio de 9 expertos, un ítem fue eliminado y 19 corregidos. Se discuten los resultados para aclarar el contenido de las fases. Finalmente se presenta la Escala de la Fases del Duelo de 66 ítems tipo Likert para su posterior estudio psicométrico.